Cite

HARVARD Citation

    Kellner, C. et al. (2018). Perspectives of Fc engineered antibodies in CD19 targeting immunotherapies in pediatric B-cell precursor acute lymphoblastic leukemia. Oncoimmunology. p. . [Online]. 
  
Back to record